Reproductive and developmental toxicity assessment of palbociclib, a CDK4/6 inhibitor, in Sprague-Dawley rats and New Zealand White rabbits

Reproductive Toxicology
N R CatlinG D Cappon

Abstract

Palbociclib is a selective inhibitor of the cyclin-dependent kinase (CDK) 4/6, approved for the treatment of breast cancer. We assessed the potential effects of oral administration of palbociclib on reproduction and development. There were no effects on female or male fertility indices; however, in the male there was seminiferous tubule degeneration in the testes and secondary findings in the epididymides, lower testicular and epididymal weights, sperm density and motility. Palbociclib was not teratogenic in rats or rabbits; however, in the presence of maternal toxicity (lower maternal body weight gain and food consumption), low fetal body weights were observed in rats and small forepaw phalanges were noted in rabbits. There were, however, no adverse effects on the F1 generation in a pre- and post-natal developmental toxicity study in the rat.

Citations

Nov 29, 2020·Toxicological Sciences : an Official Journal of the Society of Toxicology·Natasha R CatlinGregg D Cappon
May 29, 2021·Journal of the National Cancer Institute·Wanyuan CuiKelly-Anne Phillips

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
D E DoddG Kimmerle
Teratogenesis, Carcinogenesis, and Mutagenesis
M D Rodríguez, H García
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology
T R HanleyB A Schwetz
© 2021 Meta ULC. All rights reserved